UNSPSC 51343102: Brivudine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C11H13BrN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2M3055079H, chemically known as uridine, 5-(2-bromovinyl)-2-deoxy-, (e)- but generally known as brivudine, which bears US NIH Compound Identifier 446727. European Medicines Agency schedules Brivudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05893MIG.

UNSPSC 51343102 Brivudine is a Commodity code that nominally addresses a specific antiviral pharmaceutical, but recent state and local solicitations tagged under this code show little activity directly aligned with brivudine procurement. The recent opportunities block contains four state and local records, none of which name brivudine as a procurement target. Instead, the tagged opportunities cover naloxone and drug deactivation systems, pharmacy benefit management and direct-to-manufacturer prescription programs, emergency medical and first aid supplies for fire departments, and multi-source generic pharmaceuticals and over-the-counter products through cooperative purchasing. This pattern suggests either a tagging mismatch in the source data or that the code is rarely used in active state and local procurement.

The issuing bodies in the block include a county health department (Seminole County, Florida), a state health and human services agency (Texas HHS Commission), a city fire department (Tampa Fire Department), and a multi-state cooperative purchasing alliance (Minnesota MMCAP serving state and local facilities across multiple jurisdictions). Geographic activity is concentrated in Florida, Texas, and Minnesota, with Oregon participating in the MMCAP cooperative. Without recent opportunities directly soliciting brivudine, the code shows insufficient signal for pursue-or-watch evaluation. The mismatch between the code's nominal scope and the actual work being procured suggests this code may not be the active pathway for pharmaceutical procurement in state and local markets.